Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Voltage-gated L-type calcium channel alpha-1D subunit | Starlite/ChEMBL | References |
Rattus norvegicus | Voltage-gated L-type calcium channel | Starlite/ChEMBL | References |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = -5.3 | Inhibition of [3H]-nitrendipine binding to L-type [Ca2+] channel in rat cortex homogenate, activity expressed as pIC50 | ChEMBL. | 9016337 |
IC50 (binding) | > 5000 nM | Inhibition of [3H]-nitrendipine binding at L-type [Ca2+] channel in rat cortex homogenate by 50%. | ChEMBL. | 7473567 |
IC50 (binding) | > 5000 nM | Inhibition of [3H]-nitrendipine binding at L-type [Ca2+] channel in rat cortex homogenate by 50%. | ChEMBL. | 7473567 |
Ki (binding) | nM | Displacement of [3H]-nitrendipine from calcium channel in rat cortex homogenate (Not Determined) | ChEMBL. | 7473567 |
Ki (binding) | 0 nM | Displacement of [3H]-nitrendipine from calcium channel in rat cortex homogenate (Not Determined) | ChEMBL. | 7473567 |
Log IC50 (binding) | = 5.3 | Inhibition of [3H]-nitrendipine binding to L-type [Ca2+] channel in rat cortex homogenate, activity expressed as pIC50 | ChEMBL. | 9016337 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
2 literature references were collected for this gene.